Amicus Brief

Joint Cases C-253/20 Novartis AG v. Impexeco NV and C-254/20 Novartis AG v. PI Pharma NV

Published: September 28, 2020

Court

Court of Justice of the European Union

Our Position

The trademark rights in relation to the trademark of the original product are not exhausted when use of that trademark is made on the generic product. Since paragraph 1 of Article 15 of the EUTMR does not apply, as the rights are not exhausted in the cases at issue, there is no reason to examine its exception (paragraph 2) and the interpretation of Articles 34-36 TFEU and the BMS criteria.

Download this Brief

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

To find out more please see our Cookies Policy and Privacy Policy.